Generic Name and Formulations:
Carisoprodol 200mg, aspirin 325mg, codeine phosphate 16mg; tabs; contains sulfites.
Various generic manufacturers
- Effectiveness of Sertraline in Depressed Patients With Advanced Chronic Kidney Disease
- Adjunctive Telmisartan's Effects on Symptoms of Schizophrenia
- Is Aspirin Use Associated With a Decreased Incidence of Depressive Symptoms?
Indications for Carisoprodol/Aspirin/Codeine:
Relief of painful musculoskeletal conditions.
1–2 tabs 4 times daily. May treat up to 2–3 weeks.
<16yrs: not established.
GI complication (eg, bleeding, perforation, obstruction) due to aspirin use. Aspirin-induced asthma. Carbamate sensitivity. NSAID allergy. Porphyria. Post-op pain management in children who have undergone tonsillectomy and/or adenoidectomy.
Risk of respiratory depression and death related to ultra-rapid metabolizers of codeine (esp. children in post-op tonsillectomy and/or adenoidectomy). Peptic ulcer. Gastritis. Acute abdominal conditions. Pancreatic or biliary duct disease. Renal or hepatic dysfunction. History of drug abuse. Asthma. COPD. Lung disease. Increased intracranial pressure. Dehydration. Use lowest effective dose for shortest duration. Elderly. Debilitated. Pregnancy (Cat.D). Nursing mothers: not recommended.
Additive effects with alcohol, CNS depressants, oral anticoagulants, hypoglycemics and plasma bound drugs (eg, methotrexate); use caution. Alcohol, NSAIDs, and oral anticoagulants increase risk of GI bleeding. May reduce antihypertensive effects with concomitant ACEIs, ARBs, beta-blockers, diuretics. Uricosurics antagonized. Urine alkalinizers or acidifiers decrease or increase, respectively, aspirin levels.
Muscle relaxant (central) + salicylate + opioid.
Dizziness, drowsiness, vertigo, ataxia, GI upset or bleeding, epigastric discomfort, tachycardia, orthostatic hypotension, facial flushing, rash, tinnitus; respiratory depression, hypotension.
Formerly known under the brand name Soma Compound w. Codeine.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Adjunctive Therapies for Bipolar Disorder Show Promise, Need More Evidence
- Improving Performance of Everyday Activities Is Critical in Schizophrenia
- Analysis Finds Lithium Maintenance Most Effective as Monotherapy in Bipolar Disorder
- Predicting Treatment-Emergent Mania to Tailor Pharmacotherapy in Bipolar Disorder
- Web-Based Intervention Targets Parental Behaviors That May Affect Adolescent Anxiety, Depression
- The Way to the Head May Be Through the Gut: Probiotics for Depression
- Suicide-Screening Toolkit Can Help Identify Youths at High Risk for Suicide
- Agoraphobia: An Evolving Understanding of Definitions and Treatment
- Parental Pressure to Diet Linked With Long-term Harm in Adolescents
- Does Access to Medical Cannabis Reduce Risk for Opioid Abuse?
- Examining Rates of Long-term Opioid Use in Youth With Psychiatric Disorders
- Mortality Rates for Substance Use Disorders, Intentional Injuries Vary Widely By Country
- Facial Emotion Recognition Differentiates Behavioral Variant Frontotemporal Dementia From MDD
- The Challenge of Helping Uninsured Patients While Protecting Practice Finances
- Antidepressants Increase Seizure Risk in Youth and Severely Depressed